Heart Failure Clinical Trial

Patient Self Monitoring to Evaluate 30 Day Post Discharge Heart Failure Outcomes

Summary

The purpose of this study is to examine the relative predictive ability of the derived monitoring instrument to determine post discharge instability and 30-day outcomes in patients discharged with HF. The primary hypothesis is that variables in the monitoring instrument, individually and combined, identify risk for 30-day outcomes. Clinical indicators of dyspnea, fatigue, orthopnea, dyspnea with exertion, daily weight, edema, heart rate, blood pressure, mental condition, medication adherence, and overall well-being will be reported by participants on a daily basis and considered indicators for 30-day outcomes of stability, re-hospitalization, or mortality.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

> 65 years of age
male and female patients admitted to the hospital with the primary diagnosis of HF with hospitalization > 24 hours
able to read and write in English
discharged to home environment

Exclusion Criteria:

a cardiac transplant candidate
experienced an acute coronary event within the previous 30 days of index hospitalization
experienced percutaneous coronary intervention or coronary artery bypass grafting within the previous 30 days of index hospitalization
end stage renal disease/hemodialysis
have a left ventricular assist device
> 400 lbs
unable to stand for 90 seconds independently

Study is for people with:

Heart Failure

Estimated Enrollment:

56

Study ID:

NCT02527759

Recruitment Status:

Completed

Sponsor:

Georgetown University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Medstar, Washington Hospital Center
Washington, D.C. District of Columbia, 20010, United States
Medstar, Georgetown University Hospital
Washington, D.C. District of Columbia, 20057, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

56

Study ID:

NCT02527759

Recruitment Status:

Completed

Sponsor:


Georgetown University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider